Latvia - Hospital Discharges for Malignant Neoplasm of Trachea, Bronchus and Lung
Since 2014, Latvia Hospital Discharges for Malignant Neoplasm of Trachea, Bronchus and Lung increased 2.2% year on year. In 2019, the country was ranked number 27 comparing other countries in Hospital Discharges for Malignant Neoplasm of Trachea, Bronchus and Lung at 3,327 Hospital Discharges. Latvia is overtaken by Chile, which was number 26 at 3,565 Hospital Discharges and is followed by Denmark with 3,297 Hospital Discharges. Germany, South Korea and Turkey respectively ranked number 2, 3 and 4 in this ranking. Turkey witnessed the best average annual growth at +3.7% per year, while Denmark recorded the worst performance at -4.8% per year.
Loading...
| Date | Units (Hospital Discharges) |
|---|---|
| 2019 | 3,327.00 |
| 2018 | 3,315.00 |
| 2017 | 3,414.00 |
| 2016 | 3,127.00 |
| 2015 | 3,072.00 |
Download all data from 2013 to 2019
How does Latvia rank in Hospital Discharges for Malignant Neoplasm of Trachea, Bronchus and Lung?
| # | 34 Countries | Units (Hospital Discharges) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Japan
|
393,400 | 2017 | NA | NA | View data | |
| 2 |
#2
Germany
|
205,653 | 2019 | +0.7 % | +0.3 % | View data | |
| 26 |
#26
Chile
|
3,565 | 2019 | +0.2 % | +1.7 % | View data | |
| 27 |
#27
Latvia
|
3,327 | 2019 | +0.4 % | +2.2 % | View data | |
| 28 |
#28
Denmark
|
3,297 | 2019 | -5.5 % | -4.8 % | View data | |